Cabilatazan, Ricky C.

HRN: 25-51-26  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/05/2024
09/10/2024
IV
600mg
Q8
S/P Ray Amputation 3rd, 4th, 5th Digit Left Foot
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: